Processa Pharmaceuticals shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.